iBio, Inc. Common Stock (NASDAQ: IBIO) last traded at $1.43, down 2.72% on the session. The quote above updates while this page is open; the figures below are drawn from iBio, Inc. Common Stock’s own filings and are restated only when a new one is published.
iBio, Inc. Common Stock trades on NASDAQ under the ticker IBIO. Its market capitalisation is $71.04 million.
Valuation measures for iBio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $71.04M |
|---|---|
| Enterprise value | $31.71M |
| Price / sales | 236.80 |
| Price / book | 0.92 |
| Beta | 2.08 |
Trailing-twelve-month figures tagged in iBio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $300.0K |
|---|---|
| Net income (TTM) | -$32.84M |
| EPS (TTM) | -$0.580 |
| Operating margin | -9653.00% |
| Return on equity | -42.35% |
| Cash | $47.63M |
Range and volume for IBIO over the past 52 weeks.
| 52-week high | $3.82 |
|---|---|
| 52-week low | $0.760 |
| Volume | 749.2K |
| Average volume | 877.1K |
| Previous close | $1.47 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.